NCT01247766View on ClinicalTrials.gov

Safety Study of Abatacept to Treat Rheumatoid Arthritis

CompletedOBSERVATIONAL

Enrollment

6,367

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions

Rheumatoid Arthritis

Sponsors

Lead Sponsor

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Arthritis Research Centre of Canada

OTHER

lead

Bristol-Myers Squibb

INDUSTRY

NCT01247766 - Safety Study of Abatacept to Treat Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter